ARYL HYDROCARBON RECEPTOR INNATE IMMUNE MODULATORS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE

$6,766,843FY2021Defense Health AgencyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators